|
1
|
Al-Samkari H and Berliner N:
Hemophagocytic lymphohistiocytosis. Annu Rev Pathol. 13:27–49.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parikh SA, Kapoor P, Letendre L, Kumar S
and Wolanskyj AP: Prognostic factors and outcomes of adults with
hemophagocytic lymphohistiocytosis. Mayo Clin Proc. 89:484–492.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gholam C, Grigoriadou S, Gilmour KC and
Gaspar HB: Familial haemophagocytic lymphohistiocytosis: Advances
in the genetic basis, diagnosis and management. Clin Exp Immunol.
163:271–283. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Henter JI, Elinder G, Soder O and Ost A:
Incidence in Sweden and clinical features of familial
hemophagocytic lymphohistiocytosis. Acta Paediatr Scand.
80:428–435. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ishii E, Ohga S, Tanimura M, Imashuku S,
Sako M, Mizutani S and Miyazaki S: Clinical and epidemiologic
studies of familial hemophagocytic lymphohistiocytosis in Japan.
Med Pediatr Oncol. 30:276–283. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schram AM and Berliner N: How I treat
hemophagocytic lymphohistiocytosis in the adult patient. Blood.
125:2908–2914. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Matsumura Y, Kuroda J, Shimura Y, Kiyota
M, Yamamoto-Sugitani M, Kobayashi T, Matsumoto Y, Horiike S and
Taniwaki M: Cyclosporine a and reduced-intensity conditioning
allogeneic stem cell transplantation for relapsed
angioimmunoblastic t cell lymphoma with hemophagocytic syndrome.
Intern Med. 51:2785–2787. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vella JE and El-Daly H: Hemophagocytic
lymphohistiocytosis in a patient with angioimmunoblastic lymphoma:
A case report and review of the literature. Int J Surg Pathol.
20:606–609. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu JT, Hwang WL, Wang RC and Teng CL:
Reduced intensity conditioning allogeneic hematopoietic stem cell
transplant could be beneficial to angioimmunoblastic T-cell
lymphoma patients with hemophagocytic lymphohistiocytosis. Ann
Hematol. 91:805–807. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu X, Zhao M, Pan B, Zhang J, Peng M, Wang
L, Hao X, Huang X, Mu R, Guo W, et al: Complete blood count
reference intervals for healthy Han Chinese adults. PLoS One.
10:e01196692015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shinya S, Masaru A, Akira H, Eisaku H and
Susumu O: Development of an assay of seven biochemical items,
HbA1c, and hematocrit using a small amount of blood collected from
the fingertip. Clin Chim Acta. 413:192–197. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Crowson CS, Rahman MU and Matteson EL:
Which measure of inflammation to use? A comparison of erythrocyte
sedimentation rate and C-reactive protein measurements from
randomized clinical trials of golimumab in rheumatoid arthritis. J
Rheumatol. 36:1606–1610. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lo YM, Chan LY, Lo KW, Leung SF, Zhang J,
Chan AT, Lee JC, Hjelm NM, Johnson PJ and Huang DP: Quantitative
analysis of cell-free Epstein-Barr virus DNA in plasma of patients
with nasopharyngeal carcinoma. Cancer Res. 59:1188–1191.
1999.PubMed/NCBI
|
|
14
|
Gu AD, Mo HY, Xie YB, Peng RJ, Bei JX,
Peng J, Li MY, Chen LZ, Feng QS, Jia WH and Zeng YX: Evaluation of
a multianalyte profiling assay and an enzyme-linked immunosorbent
assay for serological examination of Epstein-Barr virus-specific
antibody responses in diagnosis of nasopharyngeal carcinoma. Clin
Vaccine Immunol. 15:1684–1688. 2005. View Article : Google Scholar
|
|
15
|
Oboshi W, Aki K, Tada T, Watanabe T,
Yukimasa N, Ueno I, Saito K and Hosoi E: Flow cytometric evaluation
of surface CD56 expression on activated natural killer cells as
functional marker. J Med Invest. 63:199–203. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Valiathan R, Lewis JE, Melillo AB, Leonard
S, Ali KH and Asthana D: Evaluation of a flow cytometry-based assay
for natural killer cell activity in clinical settings. Scand J
Immunol. 75:455–462. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zu Y, Steinberg SM, Campo E, Hans CP,
Weisenburger DD, Braziel RM, Delabie J, Gascoyne RD,
Muller-Hermlink K, Pittaluga S, et al: Validation of tissue
microarray immunohistochemistry staining and interpretation in
diffuse large B-cell lymphoma. Leuk Lymphoma. 46:693–701. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Liu X and Chen Y: Adult systemic
Epstein-Barr virus-positive T-cell lymphoproliferative disease: A
case report. Exp Ther Med. 10:1025–1028. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Baer R, Bankier AT, Biggin MD, Deininger
PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC,
Séguin C, et al: DNA sequence and expression of the B95-8
Epstein-Barr virus genome. Nature. 310:207–211. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khan G, Coates PJ, Kangro HO and Slavin G:
Epstein Barr virus (EBV) encoded small RNAs: Targets for detection
by in situ hybridisation with oligonucleotide probes. J Clin
Pathol. 45:616–620. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Smith KJ, Skelton HG III, Giblin WL and
James WD: Cutaneous lesions of hemophagocytic syndrome in a patient
with T-cell lymphoma and active Epstein-Barr infection. J Am Acad
Dermatol. 25:919–924. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jordan MB, Allen CE, Weitzman S,
Filipovich AH and McClain KL: How I treat hemophagocytic
lymphohistiocytosis. Blood. 118:4041–4052. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Allen CE and McClain KL: Pathophysiology
and epidemiology of hemophagocytic lymphohistiocytosis. Hematology
Am Soc Hematol Educ Program. 2015:177–182. 2015.PubMed/NCBI
|
|
24
|
Takahashi N, Chubachi A, Kume M, Hatano Y,
Komatsuda A, Kawabata Y, Yanagiya N, Ichikawa Y, Miura AB and Miura
I: A clinical analysis of 52 adult patients with hemophagocytic
syndrome: The prognostic significance of the underlying diseases.
Int J Hematol. 74:209–213. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Koh MJ, Sadarangani SP, Chan YC, Chan MY,
Tan AM, Tan SH, Tay YK and Ng SB: Aggressive subcutaneous
panniculitis-like T-cell lymphoma with hemophagocytosis in two
children (subcutaneous panniculitis-like T-cell lymphoma). J Am
Acad Dermatol. 61:875–881. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Castillo JJ, Beltran BE, Bibas M, Bower M,
Collins JA, Cwynarski K, Diez-Martin JL, Hernandez-Ilizaliturri F,
Horwitz SM, Montoto S, et al: Prognostic factors in patients with
HIV-associated peripheral T-cell lymphoma: A multicenter study. Am
J Hematol. 86:256–261. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zettl A, Lee SS, Rüdiger T, Starostik P,
Marino M, Kirchner T, Ott M, Müller-Hermelink HK and Ott G:
Epstein-Barr virus-associated B-Cell lymphoproliferative disorders
in angioimmunoblastic T-cell lymphoma and peripheral T cell
lymphoma, unspecified. Am J Clin Pathol. 117:368–379. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou Y, Attygalle AD, Chuang SS, Diss T,
Ye H, Liu H, Hamoudi RA, Munson P, Bacon CM, Dogan A and Du MQ:
Angioimmunoblastic T-cell lymphoma: Histological progression
associates with EBV and HHV6B viral load. Br J Haematol. 138:44–53.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brown HA, Macon WR, Kurtin PJ and Gibson
LE: Cutaneous involvement by angioimmunoblastic T-cell lymphoma
with remarkable heterogeneous Epstein-Barr virus expression. J
Cutan Pathol. 28:432–438. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zerah ML and DeWitt CA: Cutaneous findings
in hemophagocytic lymphohistiocytosis. Dermatology. 230:234–243.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ariffin H, Lum SH, Cheok SA, Shekhar K,
Ariffin WA, Chan LL and Lin HP: Haemophagocytic lymphohistiocytosis
in Malaysian children. J Paediatr Child Health. 41:136–139. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Smith KJ, Skelton HG, Yeager J, Angritt P,
Wagner K, James WD, Giblin WJ and Lupton GP: Cutaneous
histopathologic, immunohistochemical, and clinical manifestations
inpatients with hemophagocytic syndrome. Military medical
consortium for applied retroviral research (MMCARR). Arch Dermatol.
128:193–200. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sakai H, Otsubo S, Miura T and Iizuka H:
Hemophagocytic syndrome presenting with a facial erythema in a
patient with systemic lupus erythematosus. J Am Acad Dermatol.
57:S111–S114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fardet L, Galicier L, Vignon-Pennamen MD,
Regnier S, Noguera ME, de Labarthe A, Raffoux E, Martinez V, Buyse
S, Viguier M, et al: Frequency, clinicalfeatures and prognosis of
cutaneous manifestations in adult patients with reactive
haemophagocytic syndrome. Br J Dermatol. 162:547–553. 2010.
View Article : Google Scholar : PubMed/NCBI
|
